Company: SATLW
Filing Date: 2025-04-10
Form Type: 424B5
Source: 0001437749-25-011569
Chunk: 51

Company: Satellogic Inc.
Filing Date: 2025-04-10
Form: 424B5
Chunk 51
---
 the Sponsor’s CF V Class B Common Stock acquired in connection with the formation of CF at a price of $0.003 per share, or issued to the Sponsor in exchange for the Sponsor’s CF V Class A Common Stock acquired in connection with the CF V Private Placement at a price of $10.00 per share, |

| ○ | 814,071 shares of Class A Common Stock issued to an affiliate of Sponsor in satisfaction of debt owed to them at a price of $8.00 per share, |

| ○ | 2,078,064 shares of Class A Common Stock issued to an affiliate of the Sponsor in lieu of advisory fees owed to them at a price of $8.00 per share, |

| ○ | 13,582,642 shares of Class A Common Stock issuable upon conversion of our Class B Common Stock, which were issued to Emiliano Kargieman, Nettar’s founder and the Company’s Chief Executive Officer, at the closing of the Business Combination in exchange for his ordinary and preference shares in Nettar which he received for no consideration, |

| ○ | 20,000,000 Liberty Shares issued to the Liberty Investor at a price of $7.50 per share, |

| ○ | 533,333 shares of Class A Common Stock issuable upon the exercise of the $8.63 Warrants held by the Sponsor, |

| ○ | 7,500,000 shares of Class A Common Stock issuable upon the exercise of the $10.00 Liberty Warrants held by the Liberty Investor, |

| ○ | 15,000,000 shares of Class A Common Stock issuable upon the exercise of the $15.00 Liberty Warrants held by the Liberty Investor, and |

| ○ | 25,000,000 shares of Class A Common Stock issuable upon the conversion of the Notes. |

| ● | 23,033,333 Warrants to purchase shares of Class A Common Stock (the “Offered Warrants”) which include |

| ○ | 533,333 $8.63 Warrants, |

| ○ | 7,500,000 $10.00 Liberty Warrants, and |

| ○ | 15,000,000 $15.00 Liberty Warrants. |

<div align='center'>5

RISK FACTORS</div>

Investment in any securities offered pursuant to this prospectus and any applicable prospectus supplement involves risks. You should carefully consider